Invasive serogroup B Neisseria meningitidis in Quebec, Canada, 2003 to 2010: persistence of the ST-269 clone since it first emerged in 2003.
about
Implications of differential age distribution of disease-associated meningococcal lineages for vaccine development.The changing epidemiology of meningococcal disease in Quebec, Canada, 1991-2011: potential implications of emergence of new strains.Characterization of invasive Neisseria meningitidis strains from Québec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets.Parents' and adolescents' willingness to be vaccinated against serogroup B meningococcal disease during a mass vaccination in Saguenay-Lac-St-Jean (Quebec).Characterization of invasive Neisseria meningitidis from Atlantic Canada, 2009 to 2013: With special reference to the nonpolysaccharide vaccine targets (PorA, factor H binding protein, Neisseria heparin-binding antigen and Neisseria adhesin A).Immunization for meningococcal serogroup B: What does the practitioner need to know?Controlling serogroup B invasive meningococcal disease: the Canadian perspective.Evolving meningococcal immunization strategies.Outbreaks of meningococcal B infection and the 4CMenB vaccine: historical and future perspectives.Ciprofloxacin-resistant Neisseria meningitidis in Canada: likely imported strains.Changes in the Population Structure of Invasive Neisseria meningitidis in the United States After Quadrivalent Meningococcal Conjugate Vaccine Licensure.La vaccination contre le méningocoque du sérogroupe B : ce que le praticien doit savoir.Meningitis Vaccination, Knowledge, and Awareness Among YMSM in Chicago.Increase in Neisseria meningitidis serogroup W invasive disease in Canada: 2009-2016.Enhanced surveillance of invasive meningococcal disease in Canada, 2006-2011.
P2860
Q33743483-A094574D-B41F-4CCA-9E03-DF0002181DE5Q34500581-908757AF-278A-4F17-94BC-B2F8825B61D4Q35708801-31D28987-822C-4F2F-A3F7-A30AEAE97F91Q35867241-D184D6B0-95D7-4C87-A00D-F40802F3CDC9Q36407498-0A887A94-4E2C-4B14-941F-C0AD77B7BEB0Q37615932-04BCA079-E613-49C3-92ED-9D072A6DC81EQ38105338-9ED9A872-8FB3-4C9A-832E-717A2C19CA12Q38286082-D51B8B97-DACA-4492-BAA3-CF8EB47CE92BQ38325374-C4AA5C26-E2D6-40EE-9AA4-4FC145B5CC9DQ38402991-D4A2C108-730C-45D2-977B-7225ACE0492EQ41565209-EA3F3F00-7C50-4868-AA2C-EEBCC22A2A72Q45946720-68584DEB-E241-4249-B911-DD92EEA118BAQ48258729-3183E4B0-3503-4771-93A5-5BBDCF14F6FCQ55003926-F6727F70-0AF8-4CF7-94F8-3073EC7838A2Q55191650-59600157-05E2-4042-8B94-C3FA96AB6746
P2860
Invasive serogroup B Neisseria meningitidis in Quebec, Canada, 2003 to 2010: persistence of the ST-269 clone since it first emerged in 2003.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Invasive serogroup B Neisseria ...... ince it first emerged in 2003.
@ast
Invasive serogroup B Neisseria ...... ince it first emerged in 2003.
@en
type
label
Invasive serogroup B Neisseria ...... ince it first emerged in 2003.
@ast
Invasive serogroup B Neisseria ...... ince it first emerged in 2003.
@en
prefLabel
Invasive serogroup B Neisseria ...... ince it first emerged in 2003.
@ast
Invasive serogroup B Neisseria ...... ince it first emerged in 2003.
@en
P2093
P2860
P356
P1476
Invasive serogroup B Neisseria ...... ince it first emerged in 2003.
@en
P2093
Brigitte Lefebvre
Dennis K S Law
Genevieve Deceuninck
Jianwei Zhou
Philippe De Wals
Raymond S W Tsang
Rodica Gilca
P2860
P304
P356
10.1128/JCM.06835-11
P407
P577
2012-02-15T00:00:00Z